108 related articles for article (PubMed ID: 27866687)
21. Glibenclamide nanosuspension inhaler: development,
Hashem FM; Abd Allah FI; Abdel-Rashid RS; Hassan AAA
Drug Dev Ind Pharm; 2020 May; 46(5):762-774. PubMed ID: 32250179
[No Abstract] [Full Text] [Related]
22. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
[TBL] [Abstract][Full Text] [Related]
23. Microwave as skin permeation enhancer for transdermal drug delivery of chitosan-5-fluorouracil nanoparticles.
Nawaz A; Wong TW
Carbohydr Polym; 2017 Feb; 157():906-919. PubMed ID: 27988008
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
25. [Enhancing effect of switching iontophoresis on transdermal absorption of glibenclamide].
Takahashi Y; Iwata M; Machida Y
Yakugaku Zasshi; 2001 Feb; 121(2):161-6. PubMed ID: 11218730
[TBL] [Abstract][Full Text] [Related]
26. Insulin nanoparticles for transdermal delivery: preparation and physicochemical characterization and in vitro evaluation.
Zhao X; Zu Y; Zu S; Wang D; Zhang Y; Zu B
Drug Dev Ind Pharm; 2010 Oct; 36(10):1177-85. PubMed ID: 20367030
[TBL] [Abstract][Full Text] [Related]
27. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
[TBL] [Abstract][Full Text] [Related]
28. Transdermal delivery of insulin using microneedle rollers in vivo.
Zhou CP; Liu YL; Wang HL; Zhang PX; Zhang JL
Int J Pharm; 2010 Jun; 392(1-2):127-33. PubMed ID: 20347024
[TBL] [Abstract][Full Text] [Related]
29. Improved anti-diabetic activity of glibenclamide using oral self nano emulsifying powder.
Bari A; Chella N; Sanka K; Shastri NR; Diwan PV
J Microencapsul; 2015; 32(1):54-60. PubMed ID: 25090596
[TBL] [Abstract][Full Text] [Related]
30. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin.
Rastogi R; Anand S; Koul V
Drug Dev Ind Pharm; 2010 Nov; 36(11):1303-11. PubMed ID: 20849347
[TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
32. SRMS142-based solid lipid microparticles: application in oral delivery of glibenclamide to diabetic rats.
Nnamani PO; Attama AA; Ibezim EC; Adikwu MU
Eur J Pharm Biopharm; 2010 Sep; 76(1):68-74. PubMed ID: 20554020
[TBL] [Abstract][Full Text] [Related]
33. Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats.
King MJ; Badea I; Solomon J; Kumar P; Gaspar KJ; Foldvari M
Diabetes Technol Ther; 2002; 4(4):479-88. PubMed ID: 12396742
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
35. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
36. Glibenclamide Mini-tablets with an Enhanced Pharmacokinetic and Pharmacodynamic Performance.
Tawfeek HM; Roberts M; El Hamd MA; Abdellatif AAH; Younis MA
AAPS PharmSciTech; 2018 Oct; 19(7):2948-2960. PubMed ID: 30027418
[TBL] [Abstract][Full Text] [Related]
37. QbD-based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes.
Prasad PS; Imam SS; Aqil M; Sultana Y; Ali A
Drug Deliv; 2016; 23(3):1057-66. PubMed ID: 25033041
[TBL] [Abstract][Full Text] [Related]
38. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
39. In vitro efficacy and release study with anti-inflammatory drugs incorporated in adhesive transdermal drug delivery systems.
Meyer S; Peters N; Mann T; Wolber R; Pörtner R; Nierle J
J Pharm Sci; 2014 Apr; 103(4):1142-8. PubMed ID: 24633817
[TBL] [Abstract][Full Text] [Related]
40. Pramipexole nanocrystals for transdermal permeation: Characterization and its enhancement micro-mechanism.
Li Y; Wang D; Lu S; Zeng L; Wang Y; Song W; Liu J
Eur J Pharm Sci; 2018 Nov; 124():80-88. PubMed ID: 30076954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
